PAVmed Valuation
| PAVM Stock | USD 10.99 0.19 1.76% |
At this time, the entity appears to be undervalued. PAVmed Inc holds a recent Real Value of $78.78 per share. The prevailing price of the entity is $10.99. Our model determines the value of PAVmed Inc from inspecting the entity fundamentals such as Profit Margin of 106.72 %, shares outstanding of 921.28 K, and Return On Asset of -0.37 as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting PAVmed's valuation include:
Price Book 1.2011 | Enterprise Value | Enterprise Value Ebitda 27.1327 | Price Sales 343.0992 | Enterprise Value Revenue 1.5 K |
Undervalued
Today
Please note that PAVmed's price fluctuation is not too volatile at this time. Calculation of the real value of PAVmed Inc is based on 3 months time horizon. Increasing PAVmed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the PAVmed stock is determined by what a typical buyer is willing to pay for full or partial control of PAVmed Inc. Since PAVmed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PAVmed Stock. However, PAVmed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 10.99 | Real 78.78 | Target 285.0 | Hype 11.5 |
The intrinsic value of PAVmed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence PAVmed's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of PAVmed Inc helps investors to forecast how PAVmed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PAVmed more accurately as focusing exclusively on PAVmed's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use PAVmed's intrinsic value based on its ongoing forecasts of PAVmed's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against PAVmed's closest peers.
PAVmed Cash |
|
PAVmed Total Value Analysis
PAVmed Inc is at this time anticipated to have valuation of 43.66 M with market capitalization of 9.95 M, debt of 31.86 M, and cash on hands of 68.47 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the PAVmed fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
43.66 M | 9.95 M | 31.86 M | 68.47 M |
PAVmed Investor Information
About 18.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.2. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PAVmed Inc recorded a loss per share of 12.0. The entity had not issued any dividends in recent years. The firm had 1:30 split on the 2nd of January 2026. Based on the measurements of operating efficiency obtained from PAVmed's historical financial statements, PAVmed Inc may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.PAVmed Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. PAVmed has an asset utilization ratio of 9.77 percent. This suggests that the Company is making $0.0977 for each dollar of assets. An increasing asset utilization means that PAVmed Inc is more efficient with each dollar of assets it utilizes for everyday operations.PAVmed Profitability Analysis
Based on the measurements of profitability obtained from PAVmed's financial statements, PAVmed's profitability may be sliding down. It has an above-average probability of reporting lower numbers next quarter. Profitability indicators assess PAVmed's ability to earn profits and add value for shareholders.Net Income | First Reported 2014-06-30 | Previous Quarter -11.9 M | Current Value -5.4 M | Quarterly Volatility 13.3 M |
For PAVmed profitability analysis, we use financial ratios and fundamental drivers that measure the ability of PAVmed Inc to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well PAVmed utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between PAVmed's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of PAVmed over time as well as its relative position and ranking within its peers.
PAVmed Earnings per Share Projection vs Actual
The next projected EPS of PAVmed is estimated to be -2.4 with future projections ranging from a low of -2.4 to a high of -2.4. PAVmed's most recent 12-month trailing earnings per share (EPS TTM) is at -12.0. Please be aware that the consensus of earnings estimates for PAVmed Inc is based on EPS before non-recurring items and includes expenses related to employee stock options.PAVmed Earnings Estimation Breakdown
The calculation of PAVmed's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of PAVmed is estimated to be -2.4 with the future projection ranging from a low of -2.4 to a high of -2.4. Please be aware that this consensus of annual earnings estimates for PAVmed Inc is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-2.4 Lowest | Expected EPS | -2.4 Highest |
PAVmed Earnings Projection Consensus
Suppose the current estimates of PAVmed's value are higher than the current market price of the PAVmed stock. In this case, investors may conclude that PAVmed is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and PAVmed's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2025 | Current EPS (TTM) | |
| 2 | 59.27% | -0.6 | -2.4 | -12.0 |
PAVmed Ownership Allocation
PAVmed Inc holds 17.61 pct. of its outstanding shares held by insiders and 9.93 pct. owned by third-party entities.PAVmed Profitability Analysis
The company reported the previous year's revenue of 3 M. Net Income was 28.43 M with loss before overhead, payroll, taxes, and interest of (152 K).About PAVmed Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of PAVmed Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of PAVmed Inc based exclusively on its fundamental and basic technical indicators. By analyzing PAVmed's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of PAVmed's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of PAVmed. We calculate exposure to PAVmed's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of PAVmed's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -2.7 M | -2.6 M | |
| Pretax Profit Margin | 8.54 | 8.97 | |
| Operating Profit Margin | (13.37) | (14.04) | |
| Net Profit Margin | 11.96 | 12.56 | |
| Gross Profit Margin | (0.91) | (0.96) |
PAVmed Current Valuation Indicators
PAVmed's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final PAVmed's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as PAVmed, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use PAVmed's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes PAVmed's worth.When determining whether PAVmed Inc is a strong investment it is important to analyze PAVmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PAVmed's future performance. For an informed investment choice regarding PAVmed Stock, refer to the following important reports: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Will Health Care Equipment & Supplies sector continue expanding? Could PAVmed diversify its offerings? Factors like these will boost the valuation of PAVmed. Anticipated expansion of PAVmed directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every PAVmed data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (12.00) | Revenue Per Share | Quarterly Revenue Growth (0.99) | Return On Assets | Return On Equity |
Understanding PAVmed Inc requires distinguishing between market price and book value, where the latter reflects PAVmed's accounting equity. The concept of intrinsic value - what PAVmed's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push PAVmed's price substantially above or below its fundamental value.
It's important to distinguish between PAVmed's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PAVmed should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, PAVmed's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.